Cenway Technologies Competitors and Similar CompaniesClear all

Cenway Technologies's competitors and similar companies include 1847 Holdings, Lifco and Fina Biotech.

	Cenway Technologies Cenway Technologies (also known as Zhejiang Cenway New Materials, 浙江信汇新材料股份有限公司) is a strategic investment group that focuses on engineering and technology research, project incubation and enterprise operation.	1847 Holdings 1847 Holdings is an acquisition holding company focused on acquiring and managing a group of small businesses.	Lifco Lifco is an investment company that is engaged in the acquisition and development of niche companies.	Fina Biotech Fina Biotech (formerly known as Indas Biotech) is a company that selects, finances, conducts, develops, and markets biotechnology projects.
Founding Date	Founding Date 2001	Founding Date 2013	Founding Date 1946	Founding Date 2002
Type	Type Subsidiary	Type Public	Type Public	Type Private
Tags	Tags Investment advanced materials biotech conglomerates	Tags Investment conglomerates holding company	Tags Investment conglomerates market research	Tags Investment biotech venture capital
Locations	Locations HQ	Locations New York, US HQ	Locations Enköping, SE HQ	Locations HQ
Employees	Employees 22	Employees 1	Employees 7,424	Employees 4
Valuation ($)	Valuation ($) N/A	Valuation ($) 328.5 k	Valuation ($) 13.9 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $48.3m (FY, 2025)	Revenue (est.) kr28.3b (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $24.4m (FY, 2025)	Cost of goods kr15.7b (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $23.9m (FY, 2025)	Gross profit kr12.8b (FY, 2025)	Gross profit N/A
Net income	Net income N/A	Net income $65.6m (FY, 2025)	Net income kr3.7b (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 8m	Total funding raised N/A	Total funding raised $ 55.8k